5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.98▲ | 0.98▲ | 0.98▲ | 1.02▼ | 1.02▼ |
MA10 | 0.99▼ | 0.99▼ | 1.00▼ | 0.99▼ | 1.14▼ |
MA20 | 1.01▼ | 1.01▼ | 1.00▼ | 1.00▼ | 1.36▼ |
MA50 | 1.01▼ | 1.00▼ | 1.00▼ | 1.17▼ | 2.17▼ |
MA100 | 1.01▼ | 1.02▼ | 1.04▼ | 1.39▼ | 2.07▼ |
MA200 | 1.03▼ | 1.15▼ | 1.26▼ | 2.00▼ | 2.65▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | -0.004▼ | -0.004▼ | 0.015▲ | -0.004▼ |
RSI | 38.095▼ | 41.346▼ | 43.515▼ | 41.078▼ | 31.705▼ |
STOCH | 5.770▼ | 5.632▼ | 10.467▼ | 59.459 | 8.350▼ |
WILL %R | -91.304▼ | -91.304▼ | -61.118 | -69.072 | -94.324▼ |
CCI | -63.560 | -63.255 | -65.195 | -70.567 | -82.731 |
Thursday, June 05, 2025 04:59 PM
Biotechnology Sector's Premier Strategic Partnering Event KELOWNA, BC / ACCESS Newswire / June 5, 2025 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global ...
|
Monday, May 26, 2025 06:23 PM
Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal third 2024 results along with program updates, progress in its GLP-1 trials, a capital raise and final preparations for the Phase Ib ...
|
Monday, May 19, 2025 09:06 AM
Lexaria's DehydraTECH-CBD Diabetes Study Demonstrates Weight Loss, Improved Triglyceride And Cholesterol Levels Lexaria Bioscience Corp.’s (NASDAQ: LEXX) (NASDAQ: LEXXW) diabetes animal model ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 0.99 | 1.00 | 0.95 | 0.9765 | 88,673 |
12/06/25 | 1.04 | 1.04 | 1.00 | 1.02 | 61,664 |
11/06/25 | 1.09 | 1.10 | 0.9345 | 1.04 | 1,322,104 |
10/06/25 | 1.01 | 1.04 | 1.01 | 1.04 | 47,365 |
09/06/25 | 1.02 | 1.03 | 0.9779 | 1.00 | 130,756 |
06/06/25 | 1.00 | 1.01 | 0.9744 | 0.985 | 47,915 |
05/06/25 | 0.97 | 1.00 | 0.951 | 0.9901 | 37,058 |
04/06/25 | 0.933 | 0.9659 | 0.933 | 0.9609 | 47,326 |
03/06/25 | 0.95 | 1.01 | 0.9212 | 0.9212 | 56,626 |
02/06/25 | 1.02 | 1.02 | 0.9631 | 0.9771 | 60,355 |
|
|
||||
|
|
||||
|
|